Agilent Expands Cell Analysis Portfolio with Luxcel Acquisition

SAN FRANCISCO—Agilent Technologies said today it has acquired Luxcel Biosciences for an undisclosed price, in a deal intended to expand the buyer's cell-analysis portfolio with assay kits that are designed for ease-of-use and compatible with industry-standard plate readers.The Luxcel acquisition fits the "sweet spot" parameters for purchases Agilent prefers to make, but not exclusively make, Agilent President and CEO Michael R. McMullen said during a presentation at the J.P. Morgan 36 th A